Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

6 Technology Stocks Set To Beat Estimates This Earnings Season

Published 01/13/2020, 08:20 PM
Updated 07/09/2023, 06:31 AM

Technology stocks are anticipated to see a sluggish earnings season, primarily due to continued softness in the semiconductor space.

Semiconductors, which are the building blocks of most emerging technologies like AI and IoT, reported weak sales on a year-over-year basis in October and November. Moreover, while October sales improved on a month-over-month basis, November sales declined.

The sluggishness can largely be associated with higher tariffs on electronics, thanks to the U.S.-China trade tussle. Further, lower memory chip prices are expected to have affected the growth of companies like Samsung (KS:005930).

Notably, the Korean giant provided sluggish guidance for the fourth quarter. Per a CNBC report, the company’s estimated consolidated operating profit of 7.1 trillion Korean won ($6.02 billion) indicates a decline from 10.80 trillion Korean won Samsung posted in the year-ago quarter.

Notably, the World Semiconductor Trade Statistics (WSTS) organization projects annual global semiconductor sales to decrease 12.8% in 2019.

Additionally, the restriction on sales to Huawei is expected to have dampened results of companies like Flex and Qorvo.

Nevertheless, growth in fourth-quarter PC shipments bodes well for companies like Lenovo, HP and Dell.

Although Apple’s (NASDAQ:AAPL) MacBook shipment continued to decline per IDC data, the iPhone maker is expected to have benefited from strong demand for Apple Watch 5, AirPods and App Store sales.

Growth Drivers Aplenty

Tech companies are expected to benefit from the rapid adoption of cloud computing, AI, IoT, cloud-based gaming, wearables and drones.

Furthermore, solid demand for AI-infused virtual assistants continues to drive demand for smart speakers like Amazon (NASDAQ:AMZN) Echo and Google (NASDAQ:GOOGL) Home.

Moreover, the increasing preference for online gaming, music and video-streaming services is a major growth driver. Further, the proliferation of IoT, which is facilitating connected devices and smart homes, is a key catalyst.

The accelerated deployment of 5G technology — the next-generation of wireless connectivity — is also likely to spur growth for tech companies this earnings season.

How to Make the Right Pick?

With the presence of several industry players, finding the technology stocks having the potential to beat earnings estimates can be daunting. Our proprietary methodology, however, makes it fairly simple.

You could narrow down the list of choices by looking at stocks that have the combination of a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) and a positive Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP is our proprietary methodology for determining stocks, which have the best chances to surprise with their next earnings announcement. It is the percentage difference between the Most Accurate Estimate and the Zacks Consensus Estimate.

Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%.

Our Choices

Given below are six technology stocks that have the right combination of elements to post an earnings beat this reporting cycle:

Andover, MA-based MKS Instruments (NASDAQ:MKSI) has an Earnings ESP of +8.41% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

The company is scheduled to report fourth-quarter 2019 results on Jan 28. The consensus mark for earnings has increased 1.9% to $1.07 per share over the past 30 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

MKS Instruments, Inc. Price and EPS Surprise

MKS Instruments, Inc. price-eps-surprise | MKS Instruments, Inc. Quote


Hong Kong-based Silicon Motion Technology (NASDAQ:SIMO) is scheduled to report fourth-quarter 2019 results on Feb 6.

The company sports a Zacks Rank #1 and has an Earnings ESP of +7.36%.

The Zacks Consensus Estimate for earnings rose 5% to 84 cents per share over the past month.


San Jose, CA-based Synaptics (NASDAQ:SYNA) flaunts a Zacks Rank #1 and an Earnings ESP of +0.69%. The company is scheduled to report second-quarter fiscal 2020 results on Feb 6.

The Zacks Consensus Estimate for earnings has decreased 1.4% to $1.44 per share over the past 30 days.

Synaptics Incorporated Price and EPS Surprise

Synaptics Incorporated price-eps-surprise | Synaptics Incorporated Quote


Israel-based Perion Network (NASDAQ:PERI) currently carries a Zacks Rank #1 and an Earnings ESP of +22.58%.

The company is set to report fourth-quarter 2019 results on Feb 12. The consensus mark for earnings has surged 45.5% to 16 cents per share over the past 30 days.

Perion Network Ltd Price and EPS Surprise

Perion Network Ltd price-eps-surprise | Perion Network Ltd Quote



Cupertino, CA-based Apple is set to report first-quarter fiscal 2020 results on Jan 28. The company has an Earnings ESP of +4.08% and a Zacks Rank #2.

The Zacks Consensus Estimate for earnings has increased 0.4% to $4.53 per share over the past 30 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Apple Inc. Price and EPS Surprise


Milford, MA-based Waters Corporation (NYSE:WAT) has a Zacks Rank #2 and an Earnings ESP of +0.83%. The company is scheduled to report fourth-quarter 2019 results on Feb 4.

The Zacks Consensus Estimate for earnings has increased by a penny to $3.02 per share over the past 30 days.

Waters Corporation Price and EPS Surprise

Waters Corporation price-eps-surprise | Waters Corporation Quote


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



MKS Instruments, Inc. (MKSI): Free Stock Analysis Report

Perion Network Ltd (PERI): Free Stock Analysis Report

Apple Inc. (AAPL): Free Stock Analysis Report

Synaptics Incorporated (SYNA): Free Stock Analysis Report

Silicon Motion Technology Corporation (SIMO): Free Stock Analysis Report

Waters Corporation (WAT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.